Connect with:
Tuesday / June 2.
HomeHealth & LifestyleEuropean to approve the usage of the first Ebola vaccine

European to approve the usage of the first Ebola vaccine

European To Approve The Usage Of The First Ebola Vaccine

Ebola vaccine is accepted for use worldwide. The World Health Organization has welcomed the decision of the European Medicines Agency to approve the usage of the first Ebola vaccine in the world.

Vaccine Evrebo, a product of Merck & Co pharmaceutical company in the USA,  has been currently utilized to inhibit the spread of Ebola within the Democratic Republic of Congo. It is also believed that American medical administrators have been considering this kind of vaccine.

CEO of WHO, Tedros Adhanom Ghebreyeus, confirmed in a new statement, “This vaccine has saved many lives in the new outbreak of Ebola and the decision of European Medicines  Agency will save more.”  The Ebola vaccine is expected to get business licenses from the European Committee in the upcoming weeks.

The recurrent outbreaks of Ebola have occurred since August 2018. Since then, it is estimated that about 225000 people have been vaccinated by the product of Merck.

European To Approve The Usage Of The First Ebola Vaccine

This is considered to be the second-largest Ebola outbreak in the world following the first one had occurred in Liberia, Guinea, and Sierra Leone in the period 2014-2016, taken 11300 lives.

Ebola is a disease caused by an infection with a group of viruses which fever,  aching muscles, sore throat would appear as the early symptoms.  Soon, patients would suffer vomit, diarrhea, and probably internal and external hemorrhages in some cases.

The virus is spread through close contact with infected animals, then, among humans through direct contact with contaminated blood, fluids or the organism of the patients, or redirect contact through contaminated environments. The incubation period lasts 2 days to 3 weeks and it’s hard to diagnose.

European To Approve The Usage Of The First Ebola Vaccine 1

CEO of WHO, Tedros Adhanom Ghebreyeus, confirmed in a new statement, “This vaccine has saved many lives in the new outbreak of Ebola and the decision of European Medicines  Agency will save more.”  The Ebola vaccine is expected to get business licenses from the European Committee in the upcoming weeks.


Loading...